Logo image of WBT

WELBILT INC (WBT) Stock Fundamental Analysis

NYSE:WBT - New York Stock Exchange, Inc. - US9490901041 - Common Stock - Currency: USD

24.01  +0.02 (+0.08%)

After market: 23.99 -0.02 (-0.08%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WBT. WBT was compared to 128 industry peers in the Machinery industry. WBT has a bad profitability rating. Also its financial health evaluation is rather negative. WBT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

WBT had positive earnings in the past year.
WBT Yearly Net Income VS EBIT VS OCF VS FCFWBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 200M -200M -400M

1.2 Ratios

Industry RankSector Rank
ROA 2.79%
ROE 17.69%
ROIC 7.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WBT Yearly ROA, ROE, ROICWBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 50 -50 100 -100

1.3 Margins

Industry RankSector Rank
OM 12.69%
PM (TTM) 4.18%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WBT Yearly Profit, Operating, Gross MarginsWBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so WBT is destroying value.
The number of shares outstanding for WBT has been increased compared to 1 year ago.
The debt/assets ratio for WBT has been reduced compared to a year ago.
WBT Yearly Shares OutstandingWBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 50M 100M
WBT Yearly Total Debt VS Total AssetsWBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.60 indicates that WBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 3.95 is on the high side and indicates that WBT has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF N/A
Altman-Z 2.6
ROIC/WACC0.87
WACC8.27%
WBT Yearly LT Debt VS Equity VS FCFWBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 500M 1B

2.3 Liquidity

A Current Ratio of 3.19 indicates that WBT has no problem at all paying its short term obligations.
WBT has a Quick Ratio of 2.43. This indicates that WBT is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.19
Quick Ratio 2.43
WBT Yearly Current Assets VS Current LiabilitesWBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

6

3. Growth

3.1 Past

WBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 208.70%, which is quite impressive.
WBT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.84% yearly.
The Revenue has grown by 36.96% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 1.22% on average over the past years.
EPS 1Y (TTM)208.7%
EPS 3Y-4%
EPS 5Y1.84%
EPS Q2Q%25%
Revenue 1Y (TTM)36.96%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.22%
Sales Q2Q%5.11%

3.2 Future

The Earnings Per Share is expected to grow by 39.56% on average over the next years. This is a very strong growth
Based on estimates for the next years, WBT will show a small growth in Revenue. The Revenue will grow by 5.39% on average per year.
EPS Next Y7.59%
EPS Next 2Y38.48%
EPS Next 3Y38.97%
EPS Next 5Y39.56%
Revenue Next Year5.37%
Revenue Next 2Y5.65%
Revenue Next 3Y5.3%
Revenue Next 5Y5.39%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
WBT Yearly Revenue VS EstimatesWBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
WBT Yearly EPS VS EstimatesWBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

WBT is valuated quite expensively with a Price/Earnings ratio of 33.82.
WBT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 26.52.
A Price/Forward Earnings ratio of 18.15 indicates a rather expensive valuation of WBT.
The average S&P500 Price/Forward Earnings ratio is at 22.25. WBT is around the same levels.
Industry RankSector Rank
PE 33.82
Fwd PE 18.15
WBT Price Earnings VS Forward Price EarningsWBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.38
WBT Per share dataWBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as WBT's earnings are expected to grow with 38.97% in the coming years.
PEG (NY)4.46
PEG (5Y)18.42
EPS Next 2Y38.48%
EPS Next 3Y38.97%

0

5. Dividend

5.1 Amount

No dividends for WBT!.
Industry RankSector Rank
Dividend Yield N/A

WELBILT INC

NYSE:WBT (7/28/2022, 8:04:00 PM)

After market: 23.99 -0.02 (-0.08%)

24.01

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-10 2022-05-10/amc
Earnings (Next)08-16 2022-08-16/bmo
Inst Owners0.02%
Inst Owner Change0%
Ins Owners0.16%
Ins Owner Change0%
Market Cap3.44B
Analysts49.09
Price Target24.48 (1.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 33.82
Fwd PE 18.15
P/S 2.2
P/FCF N/A
P/OCF N/A
P/B 9.31
P/tB N/A
EV/EBITDA 18.38
EPS(TTM)0.71
EY2.96%
EPS(NY)1.32
Fwd EY5.51%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.92
BVpS2.58
TBVpSN/A
PEG (NY)4.46
PEG (5Y)18.42
Profitability
Industry RankSector Rank
ROA 2.79%
ROE 17.69%
ROCE N/A
ROIC 7.18%
ROICexc N/A
ROICexgc 14.03%
OM 12.69%
PM (TTM) 4.18%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 3.95
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.19
Quick Ratio 2.43
Altman-Z 2.6
F-Score6
WACC8.27%
ROIC/WACC0.87
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)208.7%
EPS 3Y-4%
EPS 5Y1.84%
EPS Q2Q%25%
EPS Next Y7.59%
EPS Next 2Y38.48%
EPS Next 3Y38.97%
EPS Next 5Y39.56%
Revenue 1Y (TTM)36.96%
Revenue growth 3Y-0.91%
Revenue growth 5Y1.22%
Sales Q2Q%5.11%
Revenue Next Year5.37%
Revenue Next 2Y5.65%
Revenue Next 3Y5.3%
Revenue Next 5Y5.39%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A